MorphoSys AG Reports Non-Cash Impairment Charge of €

Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014PLANEGG and MUNICH, GERMANY / ACCESSWIRE / March 10, 2022 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) announces

Related Keywords

Germany , Boston , Massachusetts , United States , Munich , Bayern , Planegg , German , Julia Neugebauer , Myles Clouston , Exchange Commission , Linkedin , Twitter , Constellation Pharmaceuticals Inc , Constellation Pharmaceuticals , Morphosy Annual Report , Morphosys , Reports , Cash , Impairment , Charge , Billion , Goodwill , After , Consolidation , Research , Discovery , Functions , Acorresponding , Increase , Group , Operating , Expenses , 021 ,